These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3524352)

  • 1. Morphologic and functional aspects of apocrine metaplasia in dysplastic and neoplastic breast tissue.
    Bussolati G; Cattani MG; Gugliotta P; Patriarca E; Eusebi V
    Ann N Y Acad Sci; 1986; 464():262-74. PubMed ID: 3524352
    [No Abstract]   [Full Text] [Related]  

  • 2. Extramammary Paget's disease of the perianal and perineal regions. Evidence of apocrine derivation.
    Merot Y; Mazoujian G; Pinkus G; Momtaz-T K; Murphy GF
    Arch Dermatol; 1985 Jun; 121(6):750-2. PubMed ID: 2408584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uneven distribution and significant concentration of apocrine metaplasia in lower breast quadrants.
    Benigni G; Squartini F
    Tumori; 1986 Apr; 72(2):179-82. PubMed ID: 3705191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An immunohistochemical study of normal sweat glands using an antibody to the breast cyst fluid protein (GCDFP-15)].
    Komatsu T; Tajima S; Nishikawa T
    Nihon Hifuka Gakkai Zasshi; 1989 Aug; 99(9):985-9. PubMed ID: 2689726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of a component protein of the breast cystic disease fluid with mol. wt 15,000.
    Le Doussal V; Zangerle PF; Collette J; Spyratos F; Hacene K; Briere M; Franchimont P; Gest J
    Eur J Cancer Clin Oncol; 1985 Jun; 21(6):715-25. PubMed ID: 3894034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clear cell metaplasia of the breast: a lesion showing eccrine differentiation.
    Viña M; Wells CA
    Histopathology; 1989 Jul; 15(1):85-92. PubMed ID: 2475422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunopathology of gross cystic disease fluid proteins.
    Mazoujian G; Haagensen DE
    Ann N Y Acad Sci; 1990; 586():188-97. PubMed ID: 2357000
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenomyoepithelioma of the breast with a distinctive type of apocrine adenosis.
    Eusebi V; Casadei GP; Bussolati G; Azzopardi JG
    Histopathology; 1987 Mar; 11(3):305-15. PubMed ID: 2828217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apocrine carcinoma and apocrine metaplasia.
    Yates AJ; Ahmed A
    Histopathology; 1988 Aug; 13(2):228-31. PubMed ID: 3169692
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apocrine carcinoma of the breast--a morphologic comparison of the apocrine sweat glands and the apocrine metaplastic epithelia in mastopathy].
    Tsubura A; Uemura Y; Inui T; Izumi H; Morii S
    Gan No Rinsho; 1988 Jun; 34(7):901-7. PubMed ID: 3398262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine cystic metaplasia and cancer risk.
    Andelin JB
    Hum Pathol; 1988 Jan; 19(1):121-2. PubMed ID: 3335389
    [No Abstract]   [Full Text] [Related]  

  • 15. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocrine epithelium of the breast: does it result from metaplasia?
    Viacava P; Naccarato AG; Bevilacqua G
    Virchows Arch; 1997 Sep; 431(3):205-9. PubMed ID: 9334842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 19. Apocrine cystic metaplasia: subgross pathology and prevalence in cancer-associated versus random autopsy breasts.
    Wellings SR; Alpers CE
    Hum Pathol; 1987 Apr; 18(4):381-6. PubMed ID: 3557440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apocrine metaplasia in phyllodes tumours of the breast.
    Salisbury JR; Singh LN
    Histopathology; 1986 Nov; 10(11):1211. PubMed ID: 3026944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.